Summary Voltage-gated Na + channels control neuronal excitability and are the primary target for the majority of anti-epileptic drugs. This study investigates the (sub)cellular expression patterns of three important brain-associated Na + channel ␣ subunits: Na V 1.1, Na V 1.2 and Na V 1.6 during epileptogenesis (induced by kainic acid) using time points that cover the period from induction to the chronic phase of epilepsy. Na V 1.1 immunoreactivity was persistently reduced at 1 day, 3 weeks and 2 months after SE in CA1 and CA3. About 50% of the Na V 1.1-positive interneurons was lost at one day after SE in all regions investigated. In the hilus a similar reduction in NeuN-positive neurons was found, while in the CA1 and CA3 region the loss in NeuN-positive neurons only reached 15% in the chronic phase of epilepsy. This implies a stronger shift in the balance between excitation and inhibition toward excitation in the CA1 and CA3 region than in the hilus. Na V 1.2 immunoreactivity in the inner molecular layer of the dentate gyrus was lower than control at 1 day after SE. It increased at 3 weeks and 2 months after SE in the inner molecular layer and overlapped with sprouted mossy fibers. Na V 1.6 immunoreactivity in the dendritic region of CA1 and CA3 was persistently reduced at all time-points during epileptogenesis. Some astrocytes expressed Na V 1.1 and Na V 1.6 at 3 weeks after SE.
Introduction
Voltage-gated Na + channels are essential for the generation and propagation of action potentials in excitable tissue. These channels are protein complexes composed of one ␣ subunit and two auxiliary ␤ subunits (Catterall, 2000) . The primary ␣ subunit forms the central pore of a voltage-gated Na + channel and serves as the voltage sensor. The auxiliary ␤ subunits modulate the gating kinetics of the associated ␣ subunits. They are also involved in the cell surface expression of the associated ␣ subunits (Patino and Isom, 2010) . In mammalian cells, nine ␣ subunit isoforms (Na V 1.1-Na V 1.9) are expressed (Catterall et al., 2005; Goldin et al., 2000) from which Na V 1.1, Na V 1.2, Na V 1.3 and Na V 1.6 are predominantly expressed in the central nervous system (CNS). Voltage-gated Na + channels are therapeutic targets for most antiepileptic drugs (AEDs) such as carbamazepine (CBZ), phenytoin (DPH) and lamotrigine (LTG). These AEDs target voltage-gated Na + channels in a use-and voltage-dependent manner which allows them to selectively prevent high frequency firing, with much less effects on normal action potentials.
In the rodent hippocampus, Na V 1.1 is found in the somata and proximal dendrites of principal cells and in GABAergic interneurons (Gong et al., 1999) . Recent studies, however, show that Na V 1.1 is primarily expressed in interneurons and loss-of-function mutations in Na V 1.1 cause the epileptic phenotype due to reduced inhibition of interneurons (Lorincz and Nusser, 2010; Ogiwara et al., 2007; Yu et al., 2006; Martin et al., 2010) . Na V 1.2 is mainly expressed along axons and on axon terminals (Gong et al., 1999; Lorincz and Nusser, 2010) and involved in neurotransmitter release. In rodents Na V 1.3 has the highest expression levels in the embryonic and early postnatal brain and its expression decreases to negligible levels in the adult brain. In contrast, Na V 1.3 is strongly expressed in adult human brain (Whitaker et al., 2000 (Whitaker et al., , 2001 . Na V 1.6 is strongly expressed in axon initial segments and nodes of Ranvier of axons (Debanne et al., 2011) and moderately expressed in the somata and dendrites of CA1 pyramidal cells (Lorincz and Nusser, 2010) . This localization suggests that Na V 1.6 is involved in the initiation and propagation of action potentials along axon as well as in the backpropagation of action potentials in dendrites.
Changes in biophysical properties of voltage-gated Na + currents have also been reported in various animal models of epilepsy (Ellerkmann et al., 2003; Vreugdenhil et al., 1998; Ketelaars et al., 2001; Vreugdenhil and Wadman, 1999) . Alterations in the mRNA expression of some ␣ subunits have been observed both in the epileptic human brain where the Na V 1.1/Na V 1.2 ratio increased (Lombardo et al., 1996) and in animal models of epilepsy in which changes in Na V 1.2 and Na V 1.3 were found Bartolomei et al., 1997; Aronica et al., 2001) . Changes in the expression of sodium channels may contribute to epileptogenesis, however, it is not known when, where and which specific sodium channels change during epileptogenesis. Therefore we examined for Na V 1.1, Na V 1.2 and Na V 1.6 the temporal expression during epileptogenesis and the spatial distribution over hippocampal sub-regions. To obtain sample points from the most characteristic time points during epileptogenesis (Williams et al., 2009) , we analyzed the expression patterns in rats 1 day, 3 weeks and 2 months after kainic acid induced status epilepticus (SE) representing the acute phase, the early chronic phase (when rats start to have recurrent spontaneous seizures) and the late chronic phase, when epilepsy is established and frequent spontaneous seizures are observed ).
Materials and methods

Animals
Adult male Sprague Dawley rats (Harlan CPB laboratories, Zeist, the Netherlands) (body weight: 350-550 g) were used. The rats were housed individually in a controlled environment (21 ± 1 • C; humidity: 60%; light on: 8:00 AM-8:00 PM; food and water available ad libitum). The experimental protocols followed the EU directive 2010/63/EU for animal experiments and the Dutch Experiments on Animal Act (1997), and were approved by the Dutch animal welfare committee (DEC).
Status epilepticus
In order to evoke a status epilepticus (SE), rats were given hourly injections of kainic acid (KA; 5 mg/kg i.p., Tocris, UK), or saline. The total amount of KA that was injected per rat varied from 10 to 20 mg/kg. Seizure activity was scored during the injection period and at least 4 h thereafter according to Racine's scale (class I-V seizures). KA injections were continued until class IV and V seizures were elicited for ≥3 h. Seizures were not terminated.
Electrode implantation and EEG recording
Rats were anesthetized with an intramuscular injection of ketamine (57 mg/kg; Alfasan, Woerden, The Netherlands) and xylazine (9 mg/kg; Bayer AG, Leverkussen, Germany) and placed in a stereotactic frame. In order to record hippocampal EEG in four rats a pair of insulated stainless steel electrodes (70 m wire diameter, tips 800 m apart) was implanted into the left dentate gyrus under electrophysiological control as previously described . A pair of stimulation electrodes was implanted in the angular bundle. Two weeks after recovery from the operation, each rat was transferred to a recording cage (40 cm × 40 cm × 80 cm) and connected to a recording and stimulation system (NeuroData Digital Stimulator, Cygnus Technology Inc., USA) with a shielded multi-strand cable and electrical swivel (Air Precision, Le Plessis Robinson, France). A week after habituation to the new condition, rats were injected with kainic acid to induce SE. To determine seizure frequency, continuous EEG recordings (24 h/day) were made in these rats (n = 4). Hippocampal EEG signals were amplified (10×) via a field effect transistor that connected the headset to an amplifier (20×; CyberAmp, Axon Instruments, Burlingame, CA, USA), band-pass filtered (1-60 Hz) and digitized by a computer. A seizure detection program (Harmonie, Stellate Systems, Montreal, Canada) sampled the incoming signal at a frequency of 200 Hz per channel. All EEG recordings were visually screened and seizures were confirmed by trained human observers.
Tissue preparation and histology
Rats were killed at 1 day, 3 weeks and 2 months after SE. After the rats were deeply anesthetized with pentobarbital (Nembutal, intraperitoneally, 60 mg/kg), they were perfused through the ascending aorta with 300 ml 0.37% Na 2 S solution followed by 300 ml 4% paraformaldehyde + 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). The brains were post-fixed in situ overnight at 4
• C, dissected and cryoprotected in 30% phosphate-buffered sucrose solution (pH 7.4). After overnight incubation at 4
• C, the brains were frozen in isopentane (−25
• C) and stored at −80 • C until sectioning. Horizontal brain sections of 40 m thickness were cut on a sliding microtome. A part of the sections were mounted on gelatin-coated slides and air-dried overnight at room temperature. Other sections were transferred to 0.1 M phosphate buffer (pH 7.4). As mossy fiber sprouting is commonly observed in epilepsy, we performed Timm staining to examine mossy fiber sprouting and its correlation with Na + channel expression. Sections were stained by using the Timm sulfide silver histochemical procedure of Danscher (1981) , modified by Sloviter (1982) . Slide-mounted sections were dehydrated, placed in xylene and cover-slipped for histologic examination of mossy fiber sprouting.
Immunocytochemistry
Free floating horizontal brain sections of rats (control: n = 6; 1 day: n = 6; 3 weeks: n = 5; 2 months: n = 9) from 5100 to 5600 m below cortex surface were washed in 0.05 M phosphate buffered saline (PBS), pH 7.4. The sections were incubated for 30 min in 0.3% hydrogen peroxide in 0.05 M PBS to inactivate endogenous peroxidase. The sections were then washed in 0.05 M PBS (3× 10 min) and thereafter in 0.5% Triton-X 100 (to enhance tissue penetration of the antibodies) and 0.4% bovine serum albumin (BSA) in 0.05 M PBS (1 h). The sections were incubated with rabbit anti-Na V 1.1 (1:50; Alomone Labs, Jerusalem, Israel), rabbit anti-Na V 1.2 (1:500; Alomone Labs, Jerusalem, Israel), rabbit anti-Na V 1.6 (1:200; Alomone Labs, Jerusalem, Israel) or mouse antiNeuN (Neuron Specific Nuclear Protein; 1:1000, MAB377, Millipore, Amsterdam, the Netherlands) in 0.1% Triton-X 100 and 0.4% BSA in 0.05 M PBS at room temperature for 1 h and then at 4
• C overnight. All procedures were carried out so that each batch of sections (control and experimental series) were stained in the same solution at the same time.
After overnight incubation with the primary antibodies, the sections were washed in 0.05 M PBS (3× 10 min) and then incubated for 1.5 h with biotinylated secondary antibodies which are diluted (1:200) in 0.1% Triton-X 100 and 0.4% BSA in 0.05 M PBS. The sections were washed in 0.05 M PBS (3× 10 min) and incubated for 30 min with AB-mix (Vectastain ABC kit, Peroxidase Standard pk-4000, Vector Laboratories, Burlingame, CA, USA). The sections were washed (3× 10 min) in 0.05 M Tris-HCl, pH 7.9 and then were stained with DAB solution. Components of DAB solution: 3,3 -diaminobenzidin tetrahydrochloride (30 mg, Sigma-Aldrich, Zwijndrecht, the Netherlands) and 750 l 1% hydrogen peroxide in a 100 ml solution of 0.05 M Tris-HCl, pH 7.9. The staining reaction was stopped by washing the sections in 0.05 M PB. After mounting on superfrost plus slides, the sections were air dried, dehydrated in alcohol and xylene and coverslipped with Entellan (Merck, Darmstadt, Germany).
Sections were also incubated with rabbit anti-Na V 1.3 (1:50; Alomone Labs, Jerusalem, Israel), however as no staining was visible in control or epileptic tissue, we could not include any data on Na V 1.3.
To specificity of immunocytochemistry was validated using polyclonal rabbit antibodies obtained from Glaxo SmithKline (K116 against Na V 1.1; K227 against Na V 1.2 and K179 against Na V 1.6). The expression pattern of the ␣ subunits obtained with these antibodies (supplementary figure 1) was quite comparable to those found with the antibodies that were described earlier in this paragraph, which indicates that the antibodies used in this study have similar specificity. Negative controls (omission of primary and/or secondary antibodies) did not indicate a relevant background staining.
Supplementary material related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j.eplepsyres.2013.06.006.
Fluorescent immunocytochemistry
To identify whether Na V 1.1 was expressed in interneurons, double labeling of rabbit anti-Na V 1.1 (1:50, Alomone Labs, Jerusalem, Israel) with mouse anti-GAD 67 (GAD 67, a GABAergic marker; 1:500, Millipore, Amsterdam, the Netherlands) was performed. To identify whether Na V 1.1 and Na V 1.6 were expressed in astrocytes, double labeling of rabbit anti-Na V 1.1 (1:50, Alomone Labs, Jerusalem, Israel) or rabbit anti-Na V 1.6 (1:200, Alomone Labs, Jerusalem, Israel) with mouse anti-GFAP (glial fibrillary acidic protein, the astrocyte marker; 1:500, Boehringer Mannheim Biochemica, Germany) or mouse anti-CD11b/c (the microglia marker; OX-42, 1:100, PharMingen, CA, USA) was performed. To identify dendrites, a MAP2 staining was performed (1:2000, Sigma-Aldrich, Zwijndrecht, The Netherlands). Free-floating sections were incubated with 0.5% Triton-X 100 and 0.4% bovine serum albumin (BSA) in 0.05 M PBS (1 h) followed by incubation with the above primary antibodies in 0.1% Triton-X 100 and 0.4% BSA in 0.05 M PBS at room temperature for 1 h and then at 4
• C overnight. After being washed in 0.05 M PBS (3× 10 min), the sections were incubated with Alexa Fluor 488 (goat anti-mouse IgG Alexa, 1:200, Invitrogen-Life Technologies, Breda, the Netherlands) and Alexa Fluor 546 (goat anti-rabbit IgG Alexa, 1:200, Invitrogen-Life Technologies, Breda, the Netherlands) for 1.5 h. After washing in 0.05 M PBS (3× 10 min), the sections were mounted on slides and coverslipped with Vectashield.
Data analysis
Digital images of all sections were taken under very controlled settings. Software (Adobe Photoshop) allowed to quantify staining as the mean pixel value of Na V 1.1, Na V 1.2 and Na V 1.6 expression in hippocampal subfields. The analysis was performed by an experimenter blinded to the group assignments. Changes in the number Na V 1.1-positive neurons were determined in sections of the hilus, CA3 and CA1 delineated by cytoarchitectonic characteristics. The border between CA1 and CA3 could be identified because mossy fibers of dentate gyrus (DG) granule cells terminate in the stratum lucidum of the CA3 area, while the CA1 subfield does not have this projection. In addition, neurons of the CA3 pyramidal cell layer are larger and more loosely packed compared to those of the CA1 area. Each subfield was further divided into different layers, as described by Paxinos (Paxinos, 2004) . The mean number of cells visible per surface area was calculated. The number of cells was expressed as a fraction of the control condition.
Changes in the number of NeuN-positive hilar cells were determined using the same strategy.
Changes in the number of CA3 and CA1 NeuNpositive pyramidal cells were determined in a comparable way. These cells were counted at 400× magnification using an ocular grid, consisting of 5 × 5 box segments (240 m × 240 m) that was randomly placed at two sites over the CA3 or CA1 pyramidal cell layer.
Furthermore, the surface area of the DG, CA3 and CA1 was measured. The surface area did not change compared to controls in any of the regions during epileptogenesis.
Statistical analysis
Unless otherwise mentioned, values are given as mean ± standard error of the mean (s.e.m.). Where appropriate, comparisons were made with a one-way ANOVA (degrees of freedom: 3 between groups, 21 within groups, 24 total) followed by a LSD test. p < 0.05 was assumed to indicate a significant difference.
Results
Development of spontaneous seizures
Rats in which the EEG was recorded continuously (n = 4) experienced the first seizure 9 ± 1 days after SE. Fig. 1A shows a typical electrographic seizure that lasts about 60 s and was recorded in the hippocampus 2 months after SE. A progressive increase in seizure frequency was observed throughout the twelve weeks of EEG monitoring (Fig. 1B) finally resulting in a median of around 10 seizures/day.
Expression of Na V 1.1 in hippocampal subregions
In controls ( Fig. 2A and Table 1 ), Na V 1.1 immunoreactivity was observed in the neuropil in the middle molecular layer of the DG (pixel value 127 ± 5), around the pyramidal cell layer of CA3 and CA1 (134 ± 7 and 136 ± 5) and in stratum lacunosum-moleculare of CA1 (115 ± 5). This is in agreement with previous findings (Lorincz and Nusser, 2010; Ogiwara et al., 2007; Yu et al., 2006) . The expression of Na V 1.1 around the pyramidal cell layer of CA3 and CA1 was about 15% lower at all epileptic stages compared to controls (Fig. 2B-D and Table 1) . Na V 1.1 immunoreactivity was also found in a small population of cells scattered throughout the hippocampus which Table 1 Pixel value of Na V 1.1, Na V 1.2 and Na V 1.6 expression in the hippocampus (mean according to their morphology, location and immunocytochemistry were presumably interneurons ( Fig. 2A inset) . All Na V 1.1-positive cells co-expressed GAD67 (Fig. 3A-C) . Compared to control values there were about 50% less Na V 1.1-positive cells in the hilus 3 weeks and 2 months after SE. A similar decline in Na V 1.1 cells was observed in the CA3 and CA1 region at all time points after SE (Fig. 2E) . However, for NeuN-positive cells, that represent the majority of neurons, the situation was different. In the hilus the presence of NeuN-positive neurons was about 50% lower in all epileptic groups when compared with controls (Fig. 2F ). This indicates that Na V 1.1-positive hilar cells were not preferentially lost or spared. Interestingly, one day after SE the relative reduction in NeuN-positive hilar cells was larger than that of Na V 1.1-positive hilar neurons. This suggests that Na V 1.1 reduction is not simply a consequence of general cell loss and that there is a cell type-specific time course of neurodegeneration. Our time-resolution does not allow to draw more detailed conclusions. Interestingly, the decline in the presence of NeuN-positive cells in CA3 and CA1 gradually became 15% and only reached significance at two months after SE (Fig. 2F ). In these regions Na V 1.1-positive cells were reduced by 50% at all time points after SE (Fig. 2E) . Thus, in the chronic phase a small fraction of the neurons is lost while a major decrease in Na V 1.1 expression was observed. This suggests that the disappearance of Na V 1.1 precedes neuronal loss. Na V 1.1 was also expressed in cells with glial morphology that were only abundantly present at 3 weeks after SE throughout all subfields of the hippocampus (Fig. 2C) . Na V 1.1 was then co-expressed with the astrocytic marker GFAP (Fig. 3G-I ) whereas no co-expression of Na V 1.1 with microglia marker CD11b/c was detected (Fig. 3J-L) , from which we conclude that the Na V 1.1-positive cells are astrocytes and not microglia.
Expression of Na V 1.2 in hippocampal subregions
In the DG of controls ( Fig. 4A and Table 1), Na V 1.2 staining was strongly present in the hilus (160 ± 5), moderately in the middle and outer molecular layer (144 ± 6 and 137 ± 6) and weakly in the inner molecular layer (124 ± 3; Fig. 4A inset left) . In CA3 Na V 1.2 staining was present in stratum lucidum (164 ± 5). In CA3 and CA1 Na V 1.2 strong immunoreactivity was observed in stratum oriens and stratum radiatum (168 ± 6 and 160 ± 5). Moderate Na V 1.2 staining was observed in CA1 stratum lacunosum-moleculare (138 ± 4). The pyramidal cell layer of CA3 and CA1 and the granule cell layer of the DG show minimal Na V 1.2 staining (Fig. 4A inset left) . The expression pattern of Na V 1.2 in controls is consistent with previous studies (Gong et al., 1999; Lorincz and Nusser, 2010) .
One notable difference in Na V 1.2 immunoreactivity in animals that experienced SE compared with controls is observed in the inner molecular layer of the DG. At 1 day after SE, Na V 1.2 staining was reduced (94 ± 7) compared to controls (124 ± 3) ( Fig. 4B inset and Table 1 ), but Na V 1.2 staining was higher at 3 weeks (140 ± 5) and 2 months (163 ± 10) after SE (Fig. 4C-D inset and Table 1 ). Since mossy fibers can specifically innervate the inner molecular layer of the DG after SE, a Timm staining was performed to identify whether the increase of Na V 1.2 in the inner molecular layer at three weeks and two months after SE could be associated with mossy fiber sprouting. Indeed, the Timm staining showed that mossy fibers densely invaded the inner molecular layer, which overlapped with the Na V 1.2 staining (Fig. 4D  inset right) .
Expression of Na V 1.6 in hippocampal subregions
In controls (Fig. 5A and Table 1 ), strong Na V 1.6 staining was observed in the CA3 pyramidal cell layer (157 ± 2), stratum lucidum (162 ± 2) and stratum radiatum (166 ± 3) and in the CA1 pyramidal cell layer (157 ± 3) and stratum radiatum (158 ± 2). Na V 1.6 was expressed in the somata and the apical proximal dendrites of the CA pyramidal cells (Figs. 5A inset and 6D-F) , which is in agreement with a previous study (Lorincz and Nusser, 2010) . Na V 1.6 immunoreactivity was lower at all time points during epileptogenesis in stratum lucidum and stratum Figure 2 Hippocampal expression of Na V 1.1 in control (A), at 1 day (B), 3 weeks (C) and 2 months (D) after status epileptus (SE). Insets: 8 times higher magnification of the CA1 pyramidal cell layer. Note the presence of Na V 1.1 immunoreactive neurons in controls (arrows in A) and the decline of these cells during the development of epilepsy (B-D). A Na V 1.1 immunoreactive plexus is present around the CA pyramidal cell layer which almost disappeared during the development of epilepsy (insets). Many Na V 1.1 immunoreactive cells with glial morphology are present at 3 weeks after SE (arrowheads in C, inset). Presence of Na V 1.1 (E) and NeuN (F) immunoreactive neurons (mean ± s.e.m.) in controls (n = 6), 1 day after status epilepticus (SE) (n = 6), 3 weeks after SE Figure 3 Co-localization of Na V 1.1 with GAD67, GFAP or CD11b/c. Na V 1.1 co-localized with GAD67 positive interneurons (A-C) in the hippocampus of a control rat. However, not all GAD67 positive interneurons were Na V 1.1 positive (D-F). Na V 1.1 is co-expressed with the astrocytic marker GFAP at 3 weeks after SE (G-I), but not with the microglial marker CD11b/c (J-L).
(n = 5) and 2 months after SE (n = 5) expressed as a percentage of those present in the control condition. The control condition is set to 100%. Separate graphs for changes in the hilus, CA3 and CA1 show about 50% reduction in the presence of Na V 1.1-immunoreactive neurons after SE induction. In the hilus a reduction in NeuN-positive hilar neurons is observed similar to Na V 1.1, expect at one day after SE, where about twice as many NeuN-positive cells have disappeared as Na V 1.1-positive cells. In CA3 and CA1 the reduction in Na V 1.1-positive cells not accompanied by a comparable reduction in NeuN-positive cells. Only in the chronic condition the 50% reduction in Na V 1.1 is accompanied by a 15% reduction in NeuN-positive cells. *p < 0.05; **p < 0.01 (one-way ANOVA followed by a LSD test). pcl = pyramidal cell layer, slm = stratum lacunosum-moleculare, mml = middle molecular layer. Scale bar: 250 m.
Figure 4 Hippocampal expression of Na V 1.2 in controls (A), at 1 day (B), 3 weeks (C) and 2 months (D) after status epileptus (SE).
Insets show 8 times higher magnification of the DG granule cell layer, inner and middle molecular layers. Note Na V 1.2 immunoreactivity in the inner molecular layer (insets and arrows in A-D) where it almost disappeared at 1 day after SE while it reappeared at 3 weeks and 2 months after SE. A Timm staining shows that mossy fibers are only present in the hilus in the control condition (inset in A, right) but densely invaded into the inner molecular layer at 2 months after SE (inset in D, right), indicating mossy fiber sprouting. This coincides with increased Na V 1.2 immunoreactivity in this region. Also note Na V 1.2 immunoreactivity in the outer molecular layer (arrows in B-D) where it became weak at 1 day after SE (the upper arrow in B) and became strong again at 3 weeks and 2 months after SE (the upper arrow in C and D). mf = mossy fibers, oml = outer molecular layer, mml = middle molecular layer, iml = inner molecular layer, gcl = granule cell layer. Scale bar: 250 m. radiatum, especially in the apical proximal dendrites (Table 1 and Figs . 5B-D inset and 6G-I), while dendrites were still present as shown by MAP2 staining (Fig. 6G-I ). This suggests that neurons that survive after SE express less Na V 1.6. This was confirmed by NeuN staining (Fig. 2F) . Neuronal loss in the CA areas only reached significance in the chronic epileptic phase (2 months after SE) and the reduced expression of Na V 1.6 preceded neuronal loss. This indicates that the reduced expression of Na V 1.6 cannot only be attributed to cell death in these regions at one day and 3 weeks after SE. Although neuronal loss was evident to some extent in the chronic phase, the remaining neurons express less sodium channels as shown in Fig. 6G-I and Table 1 . Na V 1.6 was also expressed in cells with glial morphology that were abundantly present at 3 weeks after SE (Fig. 5C ). Such cells were not found in controls or at other epileptic stages. Since Na V 1.6 was co-expressed with GFAP at 3 weeks after SE, but not with CD11b/c (Fig. 6A-C) , these results indicate that the Na V 1.6-positive cells observed at 3 weeks after SE are astrocytes.
Discussion
Na V 1.1 expression in interneurons and in CA3 and CA1 pyramidal cell layer
The number of Na V 1.1-positive interneurons decreased during epileptogenesis. However, as a fraction of the total number of hilar cells, their number did not change at any stage of epileptogenesis, from which we conclude that Na V 1.1-positive interneurons in the hilus are not preferentially lost or spared during epileptogenesis. In contrast, the immunoreactivity of Na V 1.1 around the CA pyramidal cell layer decreased during epileptogenesis, while many pyramidal cells were still present. Recent studies show that Na V 1.1 is primarily expressed in interneurons and loss-offunction mutations in Na V 1.1 cause the epileptic phenotype due to reduced activity in the interneurons (Lorincz and Nusser, 2010; Ogiwara et al., 2007; Yu et al., 2006; Martin et al., 2010) . Decreased Na V 1.1 immunoreactivity, especially around pyramidal cells could well be associated with Figure 5 Hippocampal expression of Na V 1.6 in control (A), at 1 day (B), 3 weeks (C) and 2 months (D) after status epilepticus (SE). Insets show 8 times higher magnification of the CA1 pyramidal cell layer and stratum radiatum (arrows in A and C, insets). In the control condition, Na V 1.6 immunoreactivity is observed in the somata and apical dendrites of the CA pyramidal cells (arrows in A, inset). At 1 day after SE, Na V 1.6 immunoreactivity in the apical dendrites and the DG inner molecular layer became obscure (arrow in B). At 3 weeks and 2 months after SE, Na V 1.6 immunoreactivity in the apical dendrites almost disappeared (arrows in C, inset). Many cells with glial morphology are present throughout the hippocampus at 3 weeks after SE (arrowheads in C inset). pcl = pyramidal cell layer, sr = stratum radiatum, sl = stratum lucidum, iml = inner molecular layer. Scale bar: 250 m. altered excitability in the CA3 and CA1 region. This observation suggests that the balance between excitation and inhibition is shifted in the direction of excitation, in the CA3 and CA1 region much stronger than in the hilus, making the latter less prone to seizures. Na V 1.2 expression in the molecular layer of the DG Na V 1.2 is predominantly localized in axonal terminals (Gong et al., 1999) . The immunoreactivity observed in the inner molecular layer of the DG may primarily originate from axonal terminals of hilar projections (van Strien et al., 2009) . The decrease in Na V 1.2 immunoreactivity at the acute stage after SE could reflect degeneration of axonal terminals from these projections or reduced expression. Na V 1.2 staining increased in this layer at later stages after SE. The enhanced Na V 1.2 expression in the inner molecular layer spatially overlapped with the Timm staining, which suggests that the Na V 1.2 expression is localized in the sprouted fibers. Na V 1.2 localization in the axon terminals has been linked to a role in regulating neurotransmitter release (Vacher et al., 2008) . The robust Na V 1.2 expression in excitatory mossy fibers could lead to strong glutamate release and higher local glutamate levels, with consequences for DG excitability. Previously we have reported a permanent down regulation of the neuronal glutamate transporter EAAC1 in the inner molecular layer (Gorter et al., 2002) in the same kainic acid epilepsy model, suggesting a higher excitability in the DG. Na V 1.6 expression in the dendritic region of CA3 and CA1 Na V 1.6 immunoreactivity was lost in the dendritic region of CA3 and CA1 at all time points during epileptogenesis. This could either reflect degeneration of dendrites, or it could result from reduced expression. Since the decrease in expression of sodium channels preceded neuronal loss, it is very likely that the expression of sodium channels was reduced at early time points during epileptogenesis. Pyramidal cell loss occurred to some extent during the chronic epileptic phase (2 months after SE), but many MAP2 positive dendrites were still present which had less Na V 1.6 expression compared to controls.
Figure 6
Co-localization of Na V 1.6 with GFAP, CD11b/c or MAP2. In controls (A), co-localization of Na V 1.6 and the astrocytic marker GFAP was not found. However, at 3 weeks after SE Na V 1.6 was co-expressed with GFAP (B) whereas it was not co-localized with the microglial marker CD11b/c (C). In controls, Na V 1.6 co-localized with MAP2 positive dendrites, but was also detected next to dendrites (D-F). During epileptogenesis, Na V 1.6 staining decreased, particularly in stratum radiatum (H, 2 months after SE), although MAP-2 positive dendrites were still present (G), indicating that Na V 1.6 did not only decrease as a result of dendritic loss in this region.
Because Na V 1.6 is the main subunit expressed in the dendrites of CA1 pyramidal cells (Lorincz and Nusser, 2010) , reduced dendritic expression could compromise the backpropagation of action potentials. It could also decrease excitability, because Na V 1.6 is an important factor for regulation of synaptic transmitter release . Double heterozygous mice (SCN1a null heterozygous and SCN8a mutation heterozygous) have a higher threshold for flurothyl-induced seizures than SCN1a null heterozygotes (Martin et al., 2007) . The proposed mechanism states that reduced Na V 1.6 function in excitatory neurons decreased their excitability and compensated for the loss of Na V 1.1 in inhibitory neurons. SCN8a null heterozygotes also had a higher threshold for kainic acid-or fluorethyl-induced seizures than wild-type littermates (Martin et al., 2007) . They kindled more slowly than wild-type littermates and their kindling-induced seizures were shorter (Blumenfeld et al., 2009) . These data suggest that there are several mechanisms by which loss of Na V 1.6 reduces excitability. Na V 1.1 and Na V 1.6 expression in astrocytes Although glial cells are traditionally considered nonexcitable, expression of voltage-gated Na + channels is reported in most glial cells of the central nervous system (Sontheimer et al., 1996; Verkhratsky and Steinhauser, 2000) . Small voltage-gated Na + currents have also been recorded in astrocytes in hippocampal slices (Sontheimer and Waxman, 1993) . In addition, increased Na + current density has been observed in astrocytes during epileptogenesis (Bordey and Sontheimer, 1998; Bordey and Spencer, 2004; O'Connor et al., 1998) , but the molecular identity of the Na + channels involved in these changes is not known (Steinhauser and Seifert, 2002) . Our study demonstrates astrocytes with Na V 1.1 and Na V 1.6 immunoreactivity specifically at three weeks after SE and not at any other time point. The enhanced expression of Na V 1.1 and Na V 1.6 in astrocytes could contribute to increased excitability (O'Connor et al., 1998) , but whether this plays a role in epileptogenesis is not clear.
Changes of sodium channels in relation to epileptogenesis
This study focused on the expression of Na V 1.1, Na V 1.2 and Na V 1.6. One day after SE, in the acute phase, we observed already changes in Na V 1.1, Na V 1.2 and Na V 1.6 expression, which suggests that they are a direct consequence of SE. These changes persisted in the early chronic phase (3 weeks after SE, when recurrent seizures start to appear) and in the late chronic phase (2 months after SE).
The enhanced expression of Na V 1.2 coincided with mossy fiber sprouting and could alter excitability in the DG. Expression further increased during epileptogenesis, therefore we suspect a more intricate relation between Na V 1.2 and epileptogenesis than only initiation by SE.
The reduced expression of Na V 1.1 around the pyramidal cell layer of CA3 and CA1 and the changes observed in Na V 1.1 expression in inhibitory interneurons are also expected to affect excitability, although the net outcome is not easy to predict. Besides insight in the ␣ subunits, a full functional interpretation also needs to include changes in Na + channel ␤ subunits which regulate the gating behavior of their associated ␣ subunits, contribute to the pharmacological profile and also help to determine excitability. Functional changes in sodium currents have been established in several models of epilepsy, although no direct relation with ␣ subunit composition has been determined. After kindling epileptogenesis, which does not lead to spontaneous seizures, a positive shift of the inactivation curve was found in CA1 pyramidal cells (Vreugdenhil et al., 1998) . Two months after kainic acid-induced SE, considerable changes in voltage dependent activation and inactivation of the sodium current resulted in an increased sodium window current and explained the enhanced excitability in CA1 pyramidal cells (Ketelaars et al., 2001) . After pilocarpine-induced SE, a down regulation (up to 30 days after SE) was found in Na V 1.1 and Na V 1.6 mRNA in DG granule cells, which was associated with a larger window current (Ellerkmann et al., 2003) .
The data we have collected do not allow to infer causality in the complex process of epileptogenesis, but they do suggest that several factors involving sodium channels are relevant. They suggest a shift in the balance between excitation and inhibition and also suggest distinct roles for hippocampal subregions. Static analysis of four time points does not provide the time resolution necessary to characterize the complex dynamics of epileptogenesis, but our observations strongly suggest that that involvement of an intricate reorganization of excitability in which many components participate, which as a final result will lead to the enhanced likelihood for seizures.
Conclusions
The expression of Na + channel ␣ subunits Na V 1.1, Na V 1.2 and Na V 1.6 in the hippocampal subfields dentate gyrus, CA1 and CA3 is quite distinct, which suggests functional relevance in particular for the regulation of excitability. The disproportional neuronal loss, the reduced expression of Na V 1.1 in inhibitory interneurons and around the pyramidal cell layer of CA3 and CA1, together with increased expression of Na V 1.2 in the inner molecular layer of the DG will effect excitability. But, decreased expression of Na V 1.6 in pyramidal cell dendrites will also contribute and may reduce excitability. Our static approach has provided insight in where interesting changes occur, but cannot analyze their causal relations. The observed non-uniform region and cell specific changes in subunit expression suggest where to focus the functional circuit approach in our attempts to understand epileptogenesis.
